-$8,000
Est. net congressional buying / selling (2 years). Updated Aug 13, 2025

Are Members of Congress Buying or Selling West Pharmaceutical Services?

No members of Congress have reported trading West Pharmaceutical Services (WST) stock in the past 90 days. The history below covers the past two years.

Congressional trading is one of the alternative data signals AltIndex tracks as part of the WST AI Score. For corporate insider activity, see WST insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.

Which Congress Members Are Trading West Pharmaceutical Services?

Member of CongressActivityTradesLast Trade
Jared Moskowitz Sold $16,000 2 Feb 13, 2025
Lisa McClain Bought $8,000 1 Jun 17, 2025

WST Congressional Trade History

Member of CongressTrade DateTypeEstimated Size
Lisa McClain Jun 17, 2025 Buy $1K – $15K
Jared Moskowitz Feb 13, 2025 Sell $1K – $15K
Jared Moskowitz Nov 8, 2024 Sell $1K – $15K

Frequently Asked Questions: West Pharmaceutical Services Congress Trading

No members of Congress have reported buying or selling WST stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.

Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.

Lisa McClain bought West Pharmaceutical Services (WST) stock most recently, on June 17, 2025.

The estimated net value of congressional trades in West Pharmaceutical Services over the past 2 years is negative, at -$8,000, meaning members of Congress have on balance sold more than they have bought.

Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.